Skip to main content
Top
Published in: Clinical Rheumatology 12/2008

01-12-2008 | Original Article

The impact of systemic sclerosis on arterial wall stiffness parameters and endothelial function

Authors: Alma Cypienė, Aleksandras Laucevicius, Algirdas Venalis, Jolanta Dadonienė, Ligita Ryliskytė, Zaneta Petrulionienė, Milda Kovaitė, Jonas Gintautas

Published in: Clinical Rheumatology | Issue 12/2008

Login to get access

Abstract

Systemic sclerosis (SSc) is characterized by thickening and fibrosis of skin and internal organs that is associated with vascular damage. SSc may lead to arterial dysfunction and premature aging of the arteries. However, its relationship with parameters of arterial wall dysfunction has not been fully explored. To determine if carotid–radial pulse wave velocity (PWV), aortic augmentation index (AIx) and endothelial function are altered in SSc patients, 17 consecutive patients with SSc and 34 age- and gender-matched controls were included in our study. PWV and AIx were assessed non-invasively by applanation tonometry. The endothelium-dependent flow-mediated dilatation (FMD) test in a brachial artery was performed by the ultrasound system. The blood investigations included serum lipid profile, glucose, and high-sensitivity CRP (hsCRP) measurements. As compared to controls, SSc patients had significantly higher medians of the AIx (p = 0.002) and the PWV (p = 0.04) and the median of the FMD was significantly lower (p = 0.001). Stepwise linear regression including comorbid factors showed that SSc was a significant independent predictor of all arterial wall parameters measures. SSc patients have increased AIx and PWV and lower FMD as compared to control subjects. The relationship between SSc and measures of arterial wall parameters still remains unclear. Though replication of the results presented here is required, we conclude that SSc has a great impact on large and conduit arteries damage.
Literature
1.
go back to reference Rodnan GP, Myerowitz RL, Justh GO (1980) Morphologic changes in the digital arteries of patients with progressive systemic sclerosis (scleroderma) and Raynaud phenomenon. Medicine (Baltimore) 59:393–408 Rodnan GP, Myerowitz RL, Justh GO (1980) Morphologic changes in the digital arteries of patients with progressive systemic sclerosis (scleroderma) and Raynaud phenomenon. Medicine (Baltimore) 59:393–408
2.
3.
go back to reference Ho M, Veale D, Eastmond C, Nuki G, Belch J (2000) Macrovascular disease and systemic sclerosis. Ann Rheum Dis 59:39–43PubMedCrossRef Ho M, Veale D, Eastmond C, Nuki G, Belch J (2000) Macrovascular disease and systemic sclerosis. Ann Rheum Dis 59:39–43PubMedCrossRef
4.
go back to reference Winkelmann RK (1976) Pathogenesis and staging of scleroderma. Acta Derm Venereol 56:83–92PubMed Winkelmann RK (1976) Pathogenesis and staging of scleroderma. Acta Derm Venereol 56:83–92PubMed
5.
go back to reference Gosse P, Taillard J, Constans J (2002) Evolution of ambulatory measurement of blood pressure and parameters of arterial stiffness over a 1-year period in patients with systemic sclerosis: ERAMS study. J Hum Hypertens 16:627–630PubMedCrossRef Gosse P, Taillard J, Constans J (2002) Evolution of ambulatory measurement of blood pressure and parameters of arterial stiffness over a 1-year period in patients with systemic sclerosis: ERAMS study. J Hum Hypertens 16:627–630PubMedCrossRef
6.
go back to reference Subcommittee for Scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23:581–590CrossRef Subcommittee for Scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23:581–590CrossRef
7.
go back to reference LeRoy EC, Black C, Fleischmajer R et al (1988) Scleroderma (systemic sclerosis) classification, subsets and pathogenesis. J Rheumatol 15:202–205PubMed LeRoy EC, Black C, Fleischmajer R et al (1988) Scleroderma (systemic sclerosis) classification, subsets and pathogenesis. J Rheumatol 15:202–205PubMed
8.
go back to reference Kelly R, Hayward C, Avolio A, O’Rourke M et al (1989) Noninvasive determination of age-related changes in the human arterial pulse. Circulation 80:1652–1659PubMed Kelly R, Hayward C, Avolio A, O’Rourke M et al (1989) Noninvasive determination of age-related changes in the human arterial pulse. Circulation 80:1652–1659PubMed
9.
go back to reference Wilkinson IB, Cockcroft JR, Webb DJ (1998) Pulse wave analysis and arterial stiffness. J Cardiovasc Pharmacol 32:S33–S37PubMed Wilkinson IB, Cockcroft JR, Webb DJ (1998) Pulse wave analysis and arterial stiffness. J Cardiovasc Pharmacol 32:S33–S37PubMed
10.
go back to reference O’Rourke MF, Gallagher DE (1996) Pulse wave analysis. J Hypertens Suppl 14:147–157CrossRef O’Rourke MF, Gallagher DE (1996) Pulse wave analysis. J Hypertens Suppl 14:147–157CrossRef
11.
go back to reference Celermajer DS, Sorensen KE, Gooch VM et al (1992) Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 340:1111–1115PubMedCrossRef Celermajer DS, Sorensen KE, Gooch VM et al (1992) Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 340:1111–1115PubMedCrossRef
12.
go back to reference Corretti MC, Anderson TJ, Benjamin AJ et al (2002) Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilatation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 39:257–265PubMedCrossRef Corretti MC, Anderson TJ, Benjamin AJ et al (2002) Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilatation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 39:257–265PubMedCrossRef
13.
go back to reference Ryliskyte L, Laucevicius A, Petrulioniene Z et al (2003) Normal ranges for flow-mediated dilatation of the brachial artery in different age groups (abstract). Atherosclerosis 4(Suppl 2):60 Ryliskyte L, Laucevicius A, Petrulioniene Z et al (2003) Normal ranges for flow-mediated dilatation of the brachial artery in different age groups (abstract). Atherosclerosis 4(Suppl 2):60
14.
go back to reference Andersen GN, Mincheva-Nilsson L, Kazzam E et al (2002) Assessment of vascular function in systemic sclerosis: indications of the development of nitrate tolerance as a result of enhanced endothelial nitric oxide production. Arthritis Rheum 46:1324–1332PubMedCrossRef Andersen GN, Mincheva-Nilsson L, Kazzam E et al (2002) Assessment of vascular function in systemic sclerosis: indications of the development of nitrate tolerance as a result of enhanced endothelial nitric oxide production. Arthritis Rheum 46:1324–1332PubMedCrossRef
15.
go back to reference Stücker M, Quinna S, Memmel U et al (2000) Macroangiopathy of the upper extremities in progressive systemic sclerosis. Eur J Med Res 19:295–302 Stücker M, Quinna S, Memmel U et al (2000) Macroangiopathy of the upper extremities in progressive systemic sclerosis. Eur J Med Res 19:295–302
16.
go back to reference Laurent S, Boutouyrie P, Lacolley P (2005) Structural and genetic bases of arterial stiffness. Hypertension 45:1050–1055PubMedCrossRef Laurent S, Boutouyrie P, Lacolley P (2005) Structural and genetic bases of arterial stiffness. Hypertension 45:1050–1055PubMedCrossRef
17.
go back to reference Cockcroft JR, Wilkinson IB, Hall IR et al (2002) Pulse-wave analysis—clinical evaluation of a noninvasive, widely applicable method for assessing endothelial function. Arterioscler Thromb Vasc Biol 22:147–152PubMedCrossRef Cockcroft JR, Wilkinson IB, Hall IR et al (2002) Pulse-wave analysis—clinical evaluation of a noninvasive, widely applicable method for assessing endothelial function. Arterioscler Thromb Vasc Biol 22:147–152PubMedCrossRef
18.
go back to reference Maki-Petaja KM, Hall FC, Booth AD et al (2006) Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factor alpha therapy. Circulation 114:1185–1192PubMedCrossRef Maki-Petaja KM, Hall FC, Booth AD et al (2006) Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factor alpha therapy. Circulation 114:1185–1192PubMedCrossRef
19.
go back to reference Lekakis J, Mavrikakis M, Papamicheal C et al (1998) Short-term estrogen administration improves abnormal endothelial function in women with systemic sclerosis and Raynaud’s phenomenon. Am Heart J 136:905–912PubMedCrossRef Lekakis J, Mavrikakis M, Papamicheal C et al (1998) Short-term estrogen administration improves abnormal endothelial function in women with systemic sclerosis and Raynaud’s phenomenon. Am Heart J 136:905–912PubMedCrossRef
20.
go back to reference Lekakis J, Papamicheal C, Mavrikakis M et al (1998) Effect of long-term estrogen therapy on brachial artery endothelial-dependent vasodilation in women with Raynaud’s phenomenon secondary to systemic sclerosis. Am J Cardiol 82:1555–1557PubMedCrossRef Lekakis J, Papamicheal C, Mavrikakis M et al (1998) Effect of long-term estrogen therapy on brachial artery endothelial-dependent vasodilation in women with Raynaud’s phenomenon secondary to systemic sclerosis. Am J Cardiol 82:1555–1557PubMedCrossRef
21.
go back to reference Sfikakis PP, Papamichael C, Stamatelopoulos KS et al (2007) Improvement of vascular endothelial function using the oral endothelin receptor antagonist bosentan in patients with systemic sclerosis. Arthritis & Rheumatism 56:1985–1993CrossRef Sfikakis PP, Papamichael C, Stamatelopoulos KS et al (2007) Improvement of vascular endothelial function using the oral endothelin receptor antagonist bosentan in patients with systemic sclerosis. Arthritis & Rheumatism 56:1985–1993CrossRef
22.
go back to reference Szücs G, Tímár O, Szekanecz Z et al (2007) Endothelial dysfunction precedes atherosclerosis in systemic sclerosis-relevance for prevention of vascular complications. Rheumatology 46:759–762PubMedCrossRef Szücs G, Tímár O, Szekanecz Z et al (2007) Endothelial dysfunction precedes atherosclerosis in systemic sclerosis-relevance for prevention of vascular complications. Rheumatology 46:759–762PubMedCrossRef
23.
go back to reference Cosentino F, Osto E (2007) Aging and endothelial dysfunction. Clin Hemorheol Microcirc 37:143–147PubMed Cosentino F, Osto E (2007) Aging and endothelial dysfunction. Clin Hemorheol Microcirc 37:143–147PubMed
24.
go back to reference Constans J, Gosse P, Pellegrin J-L et al (1997) Alteration of arterial distensibility in systemic sclerosis. J Int Med 241:115–118CrossRef Constans J, Gosse P, Pellegrin J-L et al (1997) Alteration of arterial distensibility in systemic sclerosis. J Int Med 241:115–118CrossRef
25.
go back to reference Freedman RF, Girgis R, Mayes MD (1999) Endothelial and adrenergic dysfunction in Raynaud’s phenomenon and scleroderma. J Rheumatol 26:2386–2388PubMed Freedman RF, Girgis R, Mayes MD (1999) Endothelial and adrenergic dysfunction in Raynaud’s phenomenon and scleroderma. J Rheumatol 26:2386–2388PubMed
26.
go back to reference Generini S, Matucci Cerinic M (1999) Raynaud’s phenomenon and vascular disease in systemic sclerosis. Adv Exp Med Biol 455:93–100PubMed Generini S, Matucci Cerinic M (1999) Raynaud’s phenomenon and vascular disease in systemic sclerosis. Adv Exp Med Biol 455:93–100PubMed
27.
go back to reference Bunker CB, Goldsmith PC, Leslie TA et al (1996) Calcitonin gene-related peptide, endothelin-1, the cutaneous microvasculature and Raynaud’s phenomenon. Br J Dermatol 134:399–406PubMedCrossRef Bunker CB, Goldsmith PC, Leslie TA et al (1996) Calcitonin gene-related peptide, endothelin-1, the cutaneous microvasculature and Raynaud’s phenomenon. Br J Dermatol 134:399–406PubMedCrossRef
28.
go back to reference Mayes MD (2003) Endothelin and endothelin receptor antagonists in systemic rheumatic diseases [review]. Arthritis Rheum 48:1190–1199PubMedCrossRef Mayes MD (2003) Endothelin and endothelin receptor antagonists in systemic rheumatic diseases [review]. Arthritis Rheum 48:1190–1199PubMedCrossRef
29.
go back to reference Ikeda U, Yamamoto K, Maeda Y et al (1997) Endothelin-1 inhibits nitric oxide synthesis in vascular smooth muscle cells. Hypertension 29:65–69PubMed Ikeda U, Yamamoto K, Maeda Y et al (1997) Endothelin-1 inhibits nitric oxide synthesis in vascular smooth muscle cells. Hypertension 29:65–69PubMed
30.
go back to reference Bjarnegård N, Bengtsson C, Brodszki J et al (2006) Increased aortic pulse wave velocity in middle aged women with systemic lupus erythematosus. Lupus 15:644–650CrossRef Bjarnegård N, Bengtsson C, Brodszki J et al (2006) Increased aortic pulse wave velocity in middle aged women with systemic lupus erythematosus. Lupus 15:644–650CrossRef
31.
go back to reference Kahaleh MB, LeRoy EC (1999) Autoimmunity and vascular involvement in systemic sclerosis (SSc). Autoimmunity 31:195–214PubMedCrossRef Kahaleh MB, LeRoy EC (1999) Autoimmunity and vascular involvement in systemic sclerosis (SSc). Autoimmunity 31:195–214PubMedCrossRef
Metadata
Title
The impact of systemic sclerosis on arterial wall stiffness parameters and endothelial function
Authors
Alma Cypienė
Aleksandras Laucevicius
Algirdas Venalis
Jolanta Dadonienė
Ligita Ryliskytė
Zaneta Petrulionienė
Milda Kovaitė
Jonas Gintautas
Publication date
01-12-2008
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 12/2008
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-008-0958-1

Other articles of this Issue 12/2008

Clinical Rheumatology 12/2008 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.